Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Q4 2021 vs. Q3 2021
How the institutions holding Revelation Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 2 | +2 |
| Shares | 0 | 64.3K | +64.3K |
| Value | $0 | $657.0K | +$657.0K |
New holders (2)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 49,678 | $508.0K | 0.00% |
| Yakira Capital Management, Inc. | 14,600 | $149.0K | 0.02% |
Sold out (0)
Institutions that held Revelation Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.